Critical illness polyneuropathy and myopathy;Critical-illness-polyneuropathie und -myopathie

Deutsche Medizinische Wochenschrift

Volumn 136, Issue 15, 2011, Pages 769-774

  Müllges, Wolfgang ^a   Stoll, G ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

critical illness myopathy; critical illness polyneuropathy

Indexed keywords

CRITICAL ILLNESS; MYOPATHY; POLYNEUROPATHY; REVIEW;

DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; HUMANS; INTENSIVE CARE; MUSCULAR ATROPHY; NEUROLOGIC EXAMINATION; NEUROMUSCULAR DISEASES; POLYNEUROPATHIES; PROGNOSIS; QUADRIPLEGIA; VENTILATOR WEANING;

EID: 79953905091     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0031-1275805     Document Type: Review

References (39)

1. Bednarik J, Vondracek P, Dusek L et al. Risk factors for critical illness polyneuromyopathy. J Neurol 2005 252 343-351
2. Bolton C F., Gilbert J J., Hahn A F., Sibbald W F. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984 47 1223-1231
3. Bolton C F. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996 24 1408-1416
4. deJonghe B, Sharshar T, Lefaucher J P. et al. Paresis aquired in the intensive care unit: a prospective multicenter study. JAMA 2002 288 2859-2867
5. deLetter M A., Schmitz P I., Visser L H. et al. Risk factors fort he development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001 29 2281-2286
6. Druschky A, Herkert M, Radespiel-Troger M et al. Critical illness-polyneuropathy: clinical findings and cell culture assay of neurotoxicity by a prospective study. Intensive Care Med 2001 27 686-693
7. Esteban A, Frutos F, Tobin M J. et al. A comparison of four methods of weaning patients from mechanical ventilation. New Engl J Med 1995 332 345-50
8. Feasby T, Banwell B, Benstead T et al. Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfus Med Rev 2007 21 Suppl 1 S57-S107
9. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia J L. et al. Critical illness-Polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001 27 1288-1296
10. Garnacho-Montero J, Amaya-Villar R Garcia-Garmendia JL et al. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay of septic patients. Crit Care Med 2005 33 349-354
11. Guaneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicenter CRIMYNE study. J Neurol Neurosurg Psychiatry 2008 79 838-841
12. Hermanns G, Vanhorebeck I, Derde S, vanden Berghe G. Metabolic aspects of critical illness polyneuromyopathy. Crit Care Med 2009 9 suppl S391-397
13. Herridge M S., Cheung A M., Tansey C M. et al. One year outcomes in survivors of the acute respiratory distress syndrome. Engl J Med 2003 348 683-693
14. Heyland D K., Dhaliwal R, Suchner U et al. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005 31 327-337
15. Hund E. Myopathy in critically ill patients. Crit Care Med 1999 27 2544-2547
16. Intiso D, Amoruso L, Zarelli M et al. Long-term functional outcome and health status of patients with critical illness polyneuromyopathy. Acta Neurol Scand 2010; Aug 19 [epub ahead of print]
17. Khan J, Harrison T B., Rich M M. et al. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006 67 1421-1425
18. Latronico N, Fenzi F, Recupero D et al. Critical illness myopathy and neuropathy. Lancet 1996 347 1579-1582
19. Latronico N. Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both? Intensive Care Med 2003 29 1411-13
20. Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care 2005 11 126-132
21. Latronico N, Bertolini G, Guarneri B et al. Simplified electrophysiological evaluation of peripheral nerves in critically ill patients. The CRIMYNE study. Crit Care 2007 11 1 R11
22. Lefaucheur J P., Nordine P, Rodriguez P et al. Origin of ICU aquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatr 2006 77 500-506
23. Levine S, Nguyen T, Taylor N et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. New Engl J Med 2008 358 1327-1335
24. Marik P E., Zaloga G P. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 2008 34 1980-1990
25. Massa R, Carpenter S, Holland P et al. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 1992 15 1290-1298
26. Mertens H G. Disseminierte Polyneuropathie nach Koma. Nervenarzt 1961 32 71-79
27. Mohr M, Englisch L, Roth A et al. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 1997 23 1144-1149
28. Müllges W, Stoll G. Intensivmedizinische Behandlung neuromuskulärer Krankheiten. Intensivmedizin up-2-date 2009 5 209-28
29. Müllges W, Stoll G. Akuttherapie des Guillain-Berré-Syndroms und der myasthenen Krise. Erkrankungen. Akt Neurol 2010 37 474-484
30. Needham D M. Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA 2008 300 1685-1690
31. Reinhart K, Brunkhorst F M., Bone H G. et al. Prävention, Therapie und Nachsorge der Sepsis. S2k-Leitlinie der Deutschen Sepsis-Gesellschaft und Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin. 2010 www.awmf.org
32. Steinberg K P., Hudson L D., Goodman R B. et al. Efficiacy and safety of corticosteroids for persistent acute respiratory distress syndrome. New Engl J Med 2006 354 1671-1684
33. Tennila A, Salmi T, Pettila V et al. Early signs of critical illness polyneuropathy in ICU patients. Intensive Care Med 2000 26 1360-1363
34. Tjader I, Rooyackers O, Forsberg A M. et al. Effects on skeletal muscle of intravenous glutamine supplementation in ICU patients. Intensive Care Med 2004 30 266-275
35. van den Berghe C, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. New Engl J Med 2001 345 1359-1367
36. van den Berghe C, Schoenheyt K, Becx P et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005 64 1348-1353
37. Williams S, Horrocks I, Ouvrier R A. et al. Critical illness polyneuropathy and myopathy in pediatric intensive care: a review. Pediatric Crit Care Med 2007 8 18-22
38. Zifko U A., Zipko H T., Bolton C F. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 1998 159 186-193
39. Zochodne D W., Bolton C F., Wells G A. et al. Critical illness polyneuropathy. Brain 1987 110 619-642